Apoptosis pharmacological manipulation of activated programmed cell death in immunological disease

Clinical Immunotherapeutics

Volumn 5, Issue 6, 1996, Pages 413-419

  Montant, Maria Saveria Gilardini ^a   Tuosto, Loretta ^a   Piccolella, Enza ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CHELATING AGENT; CYCLOHEXIMIDE; CYCLOSPORIN A; CYTOKINE; DACTINOMYCIN; DEXAMETHASONE; ENZYME INHIBITOR; GLUCOCORTICOID; GLYCOPROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; IONOMYCIN; MONOCLONAL ANTIBODY; PROTEIN KINASE INHIBITOR; RETINOIC ACID; RETINOID; RETINOL; ROQUINIMEX;

APOPTOSIS; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029928972     PISSN: 11727039     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03259337     Document Type: Article

References (67)

1. Cohcn JJ, Apoptosis, Immunol Today 19; 14: 126-30
2. von Bohemer H, Posilive selection of lymphocytes, Cell 1994; 76:219-28
3. Sprcnt J, T and B memory cells, Cell 1994; 76: 315-22
4. Boehme SA, Lenardo MJ, Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle, F.nr J Imliiunol 1993:23: 1552-60
5. Tuosto L, Cundari F.. Gilarclini Montani MS. et al. Analysis of susceptibility of mature T lymphocytes to dexamethasoueinduced apoptosis. EurJ Immunol 1994:24: 1061-5
6. Salmon M, Pilling D. Borthwick NJ. el al. The progressive differentiation of primed T eel Is is associated with an increasing susceptibility to apoptosis. Eur J Immunol 1994: 24: 892-9
7. Tuosto L, Gilardini Montani MS, Loren/elli S. el al. Differential susceptibility to monomeric HIV gpl20-medialed apoptosis in antigen-activated CD4+ T cell populations. Eur J Immunol 1995; 25: 2907-16
8. Wesselborg S, Janssen O. KabeliU 0. Induction of activationdriven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 1993; 150: 4338-45
9. Radvanyi LG, Mills GB. Miller RG. Religation of the T cell receptor after primary aclivation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol 1993: 150: .5704-15
10. Green DR, Scott DW. Activation-induced apoptosis in lymphocytes. Curr Opin Immunol 1994; 6: 476-87
11. Banda NK, Bernier J, Kurahara DK. et al. Crosslinking CD4 by HIV gpl 20 primes T cells for activation-induced apoptosis. J Exp Med 1992: 176: 1099-106
12. Rouleau M, Mollerau B. Bernard A, et al. Mitogenic CD2 monoclonal antibody pairs predispose peripheral T cells to undergo apoptosis on interaction with a third CD2 monoclonal antibody. J Immunol 1994; 152: 4861-72
13. McConkey DJ, Hartzell P. Chow SC. et al. Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receplor complex. J Immunol 1989; 143: 1801-6
14. OdakaC,KiJ.aki H.TadakumaT. T cell receptor-mediated DN A fragmentation and cell death in T cell hyhridomas. J Immunol 1990; 144: 2096-3001
15. Critchfield JM, Racke MK. Zuniga-Pflucker JC. et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994; 263: 1139-43
16. Lenardo MJ, lnterleukin-2 programs mouse a T lymphocytes for apoptosis. Nature 1991; 353; 858-61
17. lion N, Yonehara S. Ishii A. el al. The polypeptide encoded by the cDNA tor human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-43
18. Dhein J, Walczak H, Braumler C. el al. Autocrine T-cell suicide mediated by APO-l/(Fas/CD95). Nature 1995; 373: 438-41
19. Brunner T, Mogil RJ. LaFace D. el al. Cell-autonomous F'as (CD95)/Fas ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995; 373: 441-4
20. Ju S-T, Panka DJ. Cui H. et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373: 444-X
21. Alderson MR, Armitage RJ. Maraskovsky E. et al. Fas transduce activation signals in normal human T lymphocytes. .1 FxpMed 1993: 178: 2231-5
22. Thomson C,B. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62
23. Uehara T, Miyawaki T. Ohala K. el al. Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr \irusinduced infection mononucleosis. Blood 1992: 80: 452 X
24. Leno M, Simpson RM, Bowers FS, el al, Human T lymphocytic virus 1 from a lenkemogenic cell line mediates in vivo and in vitro lymphocyte apoptosis. J Exp Med 1995; 181: 1575-80
25. Meyaard L, Otto SA, Jonker RR. et al. Programmed death of T cells in HIV-1 infection. Science 1992; 257: 217-9
26. Groux H, Torpier G, Monté D, et al, Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175:331-40
27. Finkel TH, Tudor-Williams G, Banda NK. el al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph-nodes. Nature Med 1995; I: 129-34
28. Oyaizu N, McCloskey TW, Coronesi M, et al. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 1993; 82: 3392-400
29. Hivroz C, Mazerolles F, Soûla M, et al, Human immunodeficiency virus gpl 20 and derived peptides activate protein tyrosine kinase p56 Ick in human CD4 T lymphocytes. Eur J Immunol 1993:23: 600-7
30. Hubert P, Bismuth G, Korner M, et al. HIV-1 glycoprotein gpl20 disrupts CD4-p56k'k/CD3-T cell receptor interactions and inhibitsCD3 signaling. EurJ Immunol 1995; 25: 1417-25
31. Jabado N, Le Deist F, Fisher A, et al, Interaction of HIV gpl20 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-KB and AP-1. three nuclear factors regulating interleukin-2 gene enhancer activity. EurJ Immunol 1994; 24: 2646-52
32. Debatin K-M, Fahrig-Faissner A, Enenkel-Stoodt S, et al, High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 1994; 83: 3101-9
33. Katsikis PD, Wunderlich ES, Smith ÇA, et al. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995; 181:2029-36
34. Wang Z-Q, Dudhane A, Orlikowsky T, et al. CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. EurJ Immunol 1994; 24: 1549-52
35. Westendorp MO, Frank R, Ochsenbauer C, et al, Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tal and gpl20. Nature 1995; 375: 497-500
36. Cheng J, Zhou T, Liu C. et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263: 1759-62
37. Genaro AM, Gonzalo JA, Bosca L, et al, CD2-CD48 interactions prevent apoptosis in murine B lymphocytes by upregulating bcl-2 expression. Eur J Immunol 1994; 24: 2515-21
38. Liu YJ, Joshua DE, Williams GT, et al, Mechanism of antigendriven selection in germinal centres. Nature 1989; 342: 939-41
39. Pandolfi F, Oliva A, Sacco G, et al, Fibroblast-derived factors preserve viability in vitro of inononuclear cells isolated from subjects with HIV-I infection. AIDS 1993; 7: 323-9
40. Borthwick NJ, Bofill M, Gombert W, et al. Lymphocyte activation in HIV-I infection. II. Functional defects of CD28 T cells. AIDS 1994:8:431-41
41. Tuosto L, Karr RW, Fu X-T, et al. Different regions of the Nterminal domains of HLA-DRI influence recognition of individual peptide-DRI complexes. Human Immunol 1994; 40: 312-22
42. Tuosto L, Piazza C, Moretti S. el al. Ligation of either CD2 or CD28 rescues CD4+ T cells from HIV-gpl2()-induced apo ptosis. Eur J Immunol 1995; 25: 2917-22
43. Migliorali G, Nicoletli I. Nocenlini G, et al. Dexamethasone and interleukins modulate apoptosis of murine thymocytes and peripheral T lymphocytes. Pharm Res 1994; 30: 43-52
44. Garbe A, Buck J, Hammerling U. Retinoids are important cofactors in Tcell activation. J Exp Med 1992; 176: 109-17
45. Yang Y, Vacchio MS, Ashwell JD, 9-cis-Retinoic acid inhibits activation-driven T-cell apoptosis: implication for retinoid X receptor involvement in thymocyte development. Proc Nail Acad Sei USA 1993; 90: 6170-4
46. Nielo MA, Gonzales A, Gambon F, et al, Apoplosis in human thymocyles after treatment with glucocorticoids. Clin Exp Immunol 1992; 88: 341-4
47. Bansal N, Houle A, Melnykovich G, Apoptosis: mode of cell death induced in T cell leukemia lines by dexarnethasone and other agents. FASEB J 1991:5:211-4
48. Iseki R, Mukai M, Iwata M, Regulation of T lymphocyte apoptosis: signals tor the antagonism between activation- and glucocorticoid-induceddeath. J Immunol 1991; 147:4286-92
49. Zacharchuck CM, Mercep M, Chakroborti PK, et al. Programmed T lymphocyte death. Cell activation- and steroidinduced pathways are mutually antagonistic. J Immunol 1990; 145:4037-45
50. Lu W, Salerno-Goncalves R, Yuan J, el al, Glucocorticoids rescue CD4+ T lymphocytes from activation-induced apoptosis triggered by HIV-1: implications for pathogenesis and therapy. AIDS 1995:9:35-42
51. Dianzani U, Bragardo M, Buonfiglio D, et al, Modulation of CD4 laleral interaction with lymphocyte surface molecules induced by HIV-1 gp!20. EurJ Immunol 1995; 25: 1306-11
52. Auphan N, DiDonato JA, Rosette C, et al, Immunosuppression by glucocorticoids: inhibition of NF-KB activity through induction of 1KB synthesis. Science 1995; 270: 286-90
53. Iseki R, Kudo Y, Iwata M, Early mobilization of Ca2+ is not required for glucocorticoid-induced apoptosis in thymocytes. J Immunol 1993: 151: 5198-207
54. Jenkins MK, Schwartz RH, Pardoll DM. Effects of cyclosporin A on T cell development and clonal deletion. Science 1988; 241: 1655-8
55. Grenspan HC, Aruoma Ol, Oxidative stress and apoptosis in HIV infection: a role for plant-derived metabolites with synergisticantioxidant activity. Immunol Today 1994: 15:209-12
56. Buttke TM, Sandstrom PA, Oxidalive stress as mediator of apoptosis. Immunol Today 1994; 15: 7-10
57. Hockenbery DM, Oltvai ZN, Yin X-M, et al, Bcl-2 functions in an anlioxidant pathway lo prevent apoptosis. Cell 1993; 75: 241-51
58. Sandstrom PA, Tebbey PW, Vancleaven S, et al, Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxidase deficiency. J Biol Chem 1994; 2:798-801
59. Sandstrom PA, Roberts B, Folks TM, et al, HIV gene expression enhances Tcell susceptibility to hydrogen peroxide-induced apoptosis. AIDS Res Hum Retrovir 1993; 9: 1107-13
60. Kane DJ, Sarafian TA, Anton R, et al, Bcl-2 inhibition of neuronal death: decreased generation of reactive oxygen species. Science 1993; 262: 1274-7
61. Lam M, Dubyak G, Chen L, et al, Evidence that Bcl-2 represses apoptosis by regulating endoplasmatic reticulum-associaled Ca++ fluxes. Proc Natl Acad Sei USA 1994: 91: 6569-76
62. GonJ,alo JA, Gon/ale/-Garcia A, Hedlung G. et al. Linomide inhibits programmed cell death of peripheral T cells in vivo. EurJ litimunol 1994; 24: 48-52
63. Brown DG, Sun XM. Cohen GM. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internuclcosomal fragmentation. J Biol Chem 1993; 268: 3037-39
64. Lazebnik YA, Cole S, Cooke ÇA. et al. Nuclear events of apoptosis in vitro cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J Cell Biol 1993: 123: 7-22
65. Weaver VM, Lach B. Walker PR. et al. Role of proteolysis in apoptosis: involvement of serine proteases in internucleosomal DNA fragmentation in mature thymocytes. Biochem Cell Biol 1993; 71: 488-500
66. Sarin A, Adams DH, Henkart PA. Protease inhibitors selectively block T eel! receptor-triggered programmed cell death in murine T eell hybridoma and activated peripheral T cells. J Exp Med 1993: 178: 1693-700
67. Sarin A, Clerici M, Blatt SP, et al, Inhibition of activationinduced programmed eell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors. J Immunol 1994: 153: 862-72